Arrhythmia/EP

Device Therapy for Heart Failure: Debating the Guidelines - Which Should We Really Follow?

Oct 8, 2008 14:50 EDT

Join Drs Yancy, Jessup, Lindenfeld, Saxon, and Stevenson as they discuss how similar databases can be interpreted differently. Device-based therapy is effective when selected for the right patient; but there is considerable underuse of devices, in part due to ambiguity in the guidelines.

Arrhythmia/EP

The Evolution of ICD and CRT Clinical Trials and Their Impact on Clinical Practice

Sep 30, 2008 15:00 EDT

The overall heart failure-related mortality rate in the United States has almost doubled in the past two decades. Which patients will benefit the most from the use of ICDs? Join our panel of experts, Drs Abraham, Fonarow, Francis, and Gold as they discuss the latest evidence from clinical trials.

Clinical cardiology

ICD Therapy: New Data on Quality of Life and Outcomes

Sep 10, 2008 11:00 EDT

New data on quality of life and long-term prognosis after ICD implantation for primary prevention was recently published in the New England Journal of Medicine. Join Drs Bhatt, Harrington, and Prystowsky as they review this new data and discuss the clinical context of these studies.

Arrhythmia/EP

Improving Cardiovascular Outcomes in AF

4 COMMENTS - Sep 3, 2008 14:00 EDT

For all the debates on rate vs rhythm control, contemporary analyses show little change in atrial fibrillation (AF) mortality rates in the past 20 years. Will recent developments, including novel pharmacologic agents and advances in catheter ablation, translate into meaningful clinical benefit for patients? Drs Camm, Falk, Knecht, and Hohnloser each give presentations on key issues relating to the contemporary management of patients with AF.

Arrhythmia/EP

Stroke in Pharmacologically-Managed AF

1 COMMENT - Sep 3, 2008 14:00 EDT

The rate vs rhythm AF trials suggest that rhythm-managed AF patients experience more strokes possibly due to cessation of warfarin in patients with unrecognized, asymptomatic AF. Stuart Connolly presents the ESC late-breaking ATHENA findings that challenge this viewpoint and Drs Fox, Dorian, and Steg discuss the implications and possible mechanisms.

Arrhythmia/EP

Hypertrophic cardiomyopathy (HCM) affects over one million Americans... what do you know about HCM?

9 COMMENTS - Jul 8, 2008 09:00 EDT

Hypertrophic cardiomyopathy (HCM) is a complex but common genetic heart disease that affects nearly one in 500 people in the US and often goes undiagnosed. It is characterized by abnormal thickening of the heart's chamber walls and is the most common cause of sudden cardiac death in people under age 30. Please take a moment to share your perspective on the role of HCM management with theheart.org.

Clinical cardiology

Utilization of ICD therapy: The current state of the industry

5 COMMENTS - Jun 27, 2008 10:58 EDT

Dr Eric N Prystowsky MD discusses the current utilization of ICD guidelines and strategies to improve patient care.

Clinical cardiology

Current trends in cardiac resynchronization therapy

3 COMMENTS - Jun 27, 2008 09:49 EDT

Join Drs Linde, Daubert and Gold in an intriguing discussion on the impact of cardiac resynchronization therapy on remodeling and disease progression, with a review of new data by Dr Abraham.

Arrhythmia/EP

First response: Late-breaking data on the pharmacologic management of AF

Jun 3, 2008 10:56 EDT

In the ATHENA trial, an investigational amiodarone congener prolonged time to first CV hospitalization or death in elderly AF patients. The electrophysiologists have had their say what are the implications for the rest of the cardiology community? Hear Drs Alpert, Steg and Topol give the non-EP perspective.

Arrhythmia/EP

Pioneering the future: Innovations and strategies in electrophysiology and clinical cardiology

May 27, 2008 11:30 EDT

Drs Lindsay, Brugada, Gold and Stein highlight the most recent clinical trial data demonstrating the efficacy and safety of ICDs and cardiac resynchronization therapy (CRT) devices and their potential impact on clinical practice.

Arrhythmia/EP

Late-breaking data on the pharmacologic management of AF

1 COMMENT - May 19, 2008 12:20 EDT

The ATHENA trial was a late-breaker at Heart Rhythm 2008. Join Drs Prystowsky, Hohnloser, Ruskin and Waldo as they discuss pharmacologic challenges in AF management.

Arrhythmia/EP

Improving outcomes in AF: How can we do better?

Mar 31, 2008 17:00 EDT

Join Drs Prystowsky, Alpert, Kowey and Naccarelli as they discuss AF and whether new treatments on the horizon will improve outcomes for patients.

Advances in remote monitoring: realizing the promise of integrated and comprehensive patient care

Arrhythmia/EP

Advances in remote monitoring: realizing the promise of integrated and comprehensive patient care

May 22, 2007 11:00 EDT

Join Drs Saxon, Dixon, Ewald, Gilliam and Margolis as they discuss the issues involved in proving the concept that "networked" patient care improves outcomes. Also learn as they debate on current and future device innovations that will 'close the loop' and help eliminate communication gaps in patient care.

	Extremely satisfied
	Somewhat satisfied
	Satisfied
	The tools currently available can be improved